We found that inhibition of the ISR by genetic targeting of eIF2α phosphorylation decreased viability and induced apoptosis of K562 CML cells (Fig. 1B). This evidence concerns the gene EIF2A and chronic myelogenous leukemia, BCR-ABL1 positive.